MCL coexpression mm9:3577: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
|ontology_enrichment_disease= | |ontology_enrichment_disease= | ||
|ontology_enrichment_uberon= | |ontology_enrichment_uberon= | ||
|tfbs_overrepresentation_for_novel_motifs=0.752782,0.564138,0.722405,0.801166,0.587814,0.81763,0.919454,1.17946,1.20566,1.23467,0.870507,0.906098,0.467629,0.933025,1.47843,0,1.14208,0.578045,0.448066,0.328717,0.679146,0.275782,0.932027,0.585919,0.731217,0.963352,0.437236,0.841386,0.64294,0.99159,0.825437,1.24901,0.575271,0.411696,0.608816,0.444545,1.38481,0.902078,0.536514,0.50014,0.582863,0.831295,0.261619,0.610669,0.474221,0.788421,1.05665,0.859154,0.235354,0.646474,1.12346,0.99279,0.371606,1.3966,1.41464,0.940919,0.657156,0.891887,0.425455,0.938668,1.22795,1.00308,0.494668,1.11142,0.953187,1.15459,1.55483,1.90983,1.22303,1.7608,0.700291,0.474956,3.02035,1.44925,0.416814,1.03818,0.411601,1.04436,1.20986,0.684144,0.476502,1.16055,1.00151,1.16164,1.32978,1.02517,0.568545,0.380977,1.06194,2.07346,1.62608,1.33496,1.26245,0.595071,1.31639,0.509215,0.464141,1.26539,1.05692,0.352122,0.563856,1.24872,1.37854,1.12409,1.12297,0.830796,1.18646,1.98904,1.649,0.681267,0.744607,1.38039,0.685481,0.876299,1.63327,0.580657,0.212464,0.805461,1.14346,0.559153,1.45481,1.08896,0.965352,1.04338,1.68841,1.21376,0.928483,1.25534,1.55328,0.598722,1.36093,0.792832,1.52297,0.955954,1.65529,0.273451,0.762499,0.832891,1.60513,2.44352,2.04137,1.55966,0.978551,1.26,1.11604,0.831808,1.06002,2.40374,0.765221,0.589976,0.38417,3.74474,1.39822,1.28513,0.954936,1.48249,0.993889,0.622823,0.749933,0.762177,1.61484,1.32889,1.21423,0.741984,1.11251,0.94678,0.562367,0.904334,0.135528 | |||
}} | }} |
Revision as of 23:07, 26 November 2012
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr6:83267532..83267582,- | p1@Mthfd2 |
Mm9::chr6:83267583..83267596,- | p2@Mthfd2 |
Mm9::chr7:150785954..150785983,- | p1@Cars |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0006520 | amino acid metabolic process | 0.00269568024921202 |
GO:0006423 | cysteinyl-tRNA aminoacylation | 0.00269568024921202 |
GO:0000105 | histidine biosynthetic process | 0.00269568024921202 |
GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity | 0.00269568024921202 |
GO:0004817 | cysteine-tRNA ligase activity | 0.00269568024921202 |
GO:0004486 | methylenetetrahydrofolate dehydrogenase activity | 0.00269568024921202 |
GO:0009076 | histidine family amino acid biosynthetic process | 0.00269568024921202 |
GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity | 0.00269568024921202 |
GO:0006519 | amino acid and derivative metabolic process | 0.00269568024921202 |
GO:0009308 | amine metabolic process | 0.00328380268959057 |
GO:0006807 | nitrogen compound metabolic process | 0.00345843917185193 |
GO:0019238 | cyclohydrolase activity | 0.00372510883533307 |
GO:0019752 | carboxylic acid metabolic process | 0.00437938331393147 |
GO:0006082 | organic acid metabolic process | 0.00437938331393147 |
GO:0009396 | folic acid and derivative biosynthetic process | 0.00521472373854911 |
GO:0006555 | methionine metabolic process | 0.00525840086881686 |
GO:0009086 | methionine biosynthetic process | 0.00525840086881686 |
GO:0009075 | histidine family amino acid metabolic process | 0.0055864385932362 |
GO:0006547 | histidine metabolic process | 0.0055864385932362 |
GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor | 0.0055864385932362 |
GO:0006760 | folic acid and derivative metabolic process | 0.0055864385932362 |
GO:0000097 | sulfur amino acid biosynthetic process | 0.0055864385932362 |
GO:0000049 | tRNA binding | 0.0055864385932362 |
GO:0009067 | aspartate family amino acid biosynthetic process | 0.0055864385932362 |
GO:0009066 | aspartate family amino acid metabolic process | 0.00625646831969079 |
GO:0000096 | sulfur amino acid metabolic process | 0.00687486309335938 |
GO:0044249 | cellular biosynthetic process | 0.00797887704781829 |
GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors | 0.00797887704781829 |
GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 0.00885857639858035 |
GO:0044272 | sulfur compound biosynthetic process | 0.0107954166363953 |
GO:0008652 | amino acid biosynthetic process | 0.0123796454361451 |
GO:0009058 | biosynthetic process | 0.0123796454361451 |
GO:0043038 | amino acid activation | 0.0143925238184049 |
GO:0043039 | tRNA aminoacylation | 0.0143925238184049 |
GO:0006418 | tRNA aminoacylation for protein translation | 0.0143925238184049 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 0.0143925238184049 |
GO:0016876 | ligase activity, forming aminoacyl-tRNA and related compounds | 0.0143925238184049 |
GO:0004812 | aminoacyl-tRNA ligase activity | 0.0143925238184049 |
GO:0006752 | group transfer coenzyme metabolic process | 0.0153446041292717 |
GO:0005625 | soluble fraction | 0.0153446041292717 |
GO:0009309 | amine biosynthetic process | 0.0159402589561594 |
GO:0006790 | sulfur metabolic process | 0.0159402589561594 |
GO:0006164 | purine nucleotide biosynthetic process | 0.0167345164194997 |
GO:0046483 | heterocycle metabolic process | 0.0167345164194997 |
GO:0006163 | purine nucleotide metabolic process | 0.0182718976133919 |
GO:0044271 | nitrogen compound biosynthetic process | 0.0182718976133919 |
GO:0006730 | one-carbon compound metabolic process | 0.0182718976133919 |
GO:0009108 | coenzyme biosynthetic process | 0.0192821786766828 |
GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 0.0204777483448519 |
GO:0051188 | cofactor biosynthetic process | 0.0214025459163666 |
GO:0006399 | tRNA metabolic process | 0.0218547738660344 |
GO:0006725 | aromatic compound metabolic process | 0.0242123242615664 |
GO:0009165 | nucleotide biosynthetic process | 0.0256411751555361 |
GO:0006732 | coenzyme metabolic process | 0.0327653977682705 |
GO:0009117 | nucleotide metabolic process | 0.0365986452977421 |
GO:0051186 | cofactor metabolic process | 0.0371305140389463 |
GO:0055086 | nucleobase, nucleoside and nucleotide metabolic process | 0.0378373351305979 |
GO:0032787 | monocarboxylic acid metabolic process | 0.0408054310535513 |
GO:0006139 | nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.0444730834121558 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br><br><br>
Ontology term | p-value | n |
---|---|---|
stem cell | 4.98e-09 | 97 |
somatic stem cell | 1.98e-07 | 91 |
multi fate stem cell | 1.98e-07 | 91 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |